Major Advances in Gynaecological Cancers 2020 (Part 1)

Webinar description

Date: June 25, 2020 at 18:00 CEST

 

The special live ESGO webinar on June 25, 2020, is designed to offer an overview of the primary clinical trials results on both surgical and medical treatments in six key areas, and highlight the most significant advances expected in future treatment approaches of gynaecological cancers.

This exclusive webinar will feature six leading experts, who will each present the major advances in a significant gynaecological cancers treatment area, as well as and discuss the related key findings and results of selected significant surgical and medical treatment studies presented at conferences this year.

A 10-minutes discussion and Q&A will follow each presentation, and the audience will be able to send questions during the webinar.

Learning objectives

To get acquainted to the results of major clinical trials and implication of these results in the clinical practice.

Target audience

Gynae-oncologists, medical oncologists, radiation oncologist

Scientific Program

Is secondary cytoreductive surgery in ovarian cancer a new standard of care?

Speaker: Andreas du Bois

Date: Thursday, 25th June, 18:05-18:25 (CEST)

Institute: Kliniken Essen Mitte (KEM), Germany

The PARP journey

Speaker: Jonathan Ledermann

Date: Thursday, 25th June, 18:25-18:45 (CEST)

Institute: UCL Cancer Institute at University College London, United Kindom

Immune therapy in gynaecological cancers

Speaker: Nicoletta Colombo

Date: Thursday, 25th June, 18:45-19:05 (CEST)

Insitute: IRCCS Istituto Europeo di Oncologia, Italy

The role of sentinel lymph-node biopsy in endometrial cancer patients

Speaker: Jan Persson

Date: Thursday, 25th June, 19:05-19:25 (CEST)

Institute: Obstetrik och gynekologi, Sweden

img235053048
DSC07098
223_NicolettaColombo
JanPersson_smaller2

Endometrial cancer in the era of targeted therapy

Speaker: Alexandra Leary

Date: Thursday, 25th June, 19:25-19:45 (CEST)

Institute: Institut de Cancérologie Gustave Roussy, France

Are we over treating intermediate-risk cervical cancer?

Speaker: David Cibula

Date: Thursday, 25th June, 19:45-20:05 (CEST)

Institute: Gynaecology Oncology Center, Charles University Prague, Czech Republic

????????????????????????????????????
david

Moderators

Nicole Concin

Institute: Innsbruck Medical University, Austria

DSC07109

Mansoor Raza Mirza

Institute: Oncology, Rigshospitalet, Copenhagen University Hospital, Denmark

mansoor-mirza1-e1511429090107

Registration fees

  • ESGO member* - 25 EUR
  • ESGO member - Country list A and B** - 15 EUR
  • Fellow - 15 EUR
  • Non-member - 40 EUR
  • Company - 75 EUR

 

*In order to benefit from the ESGO Membership reduced rate, membership for 2020/2021 must be valid. View the ESGO membership renewals and application.

**Categories A and B are defined according to the World Bank Country Classification of Upper-middle-income economies (List A) and Low income/Lower-middle-income economies (List B).

Presidential message

Dear colleagues,

 

Due to the ongoing COVID-19 pandemic crisis, ESGO courses and meetings have been cancelled or postponed to a later time in the year.

This comes with considerable costs.

Therefore, we need to ask you for a minor fee to participate in our future Webinars.

I want to thank you for your understanding

and hope you will join our live webinars.

Stay healthy and connected!

 

Sincerely,

Philippe Morice

ESGO President

Philippe Morice